Introduction
Antibiotics resistance has become a significant issue to deal with in the world today. How human beings consume antibiotics has changed. According to (CDC 2020), antibiotic resistance is evident in the case that germs such as bacteria and fungi do grow the ability to conquer the drugs that are originally meant to kill them. Moreover, (CDC 2020) also affirms that antibiotics resistance does not mean that the body becomes resistant to the drugs; it is the bacteria that has become more resistant to the drugs administered to kill it. This implies that the government can intervene and help to save the situation (Demirjian t al, 2015). According to (CDC 2020), antibiotics are the Centre of medical treatment but are being rendered useless. This is because it was ineffective by the ability of bacteria to grow a resistance nature. The constant antibiotic resistance also threatens the economy of a country. Also, population increase, enhance global migration, increased use of antibiotics in clinics and animal production firms, poor sanitation, and wildlife spread are but some of the factors that cause antibiotic resistome World Health Organization, (2015).
Antibiotic resistance is of importance to human nature; this is because it is a severe gobble health problem. These antibiotic-resistant bacteria can spread rapidly to family members, students, and staff-endangering communities with a more difficult to treat and the costly new strain of the infectious disease. A common misunderstanding is that the body of a person becomes resistant to certain medicines. However, they are microbes, not a drug, resilient individuals. If many medications are immune to a microbe, it can prove difficult or impossible to treat the diseases it induces (Thung et al.,2016).
A resistant infection can be transmitted to another person by someone with an infection (CDC, 2020).
Science section
In every part of the world, antibiotic resistance grows to dangerously high levels. New mechanisms for the treatment of common infectious diseases are emerging and growing around the globe. Increasing numbers of illnesses–such as influenza, tuberculosis, blood poisoning, gonorrhea, and foodborne diseases–are becoming more challenging, and sometimes unlikely, for antibiotics to be handled less effectively (Munita & Arias,2016). Where the development and spread of resistance are exacerbated when antibiotics can be purchased for use by human or animal users without prescription. Similarly, medicines are often over-prescribed and over-used by health care professionals and veterinarians in countries without standard treatment directives. We head for a post-antibiotic era without urgent action that can kill common infections and minor injuries again (Berendonk, 2015).
Legislative section
Continuous outbreak in immune antibiotic pathogens is still plaguing US health and global health. In the meantime, the research and development of new antibiotics to address the threat have been declining equally alarming. The subsequent work of IDSA lobbyists contributed to the passage in the 109th US Congress of positive legislation. Unfortunately, the statute has not been passed(Ventola, 2015). The IDSA continued working with congressional leaders on positive bipartisan measures to deal with antibiotic-resistant diseases during the 110th Congress. Nonetheless, it is not known if, amid intense public advertising and lobbying efforts (Frieri et al., 2017), adequately effective regulation will be introduced. In the meantime, the antibiotic pipeline continues to be more resistant and the critical situation is still not known to the public (Chellat et al., 2016). A coordinated, collaborative initiative driven by the medical community is needed to combat the antimicrobial resistance epidemic. Nevertheless, I think that if the government can legislate a law that, for a viral infection such as colds or flu, nobody can take an antibiotic (Blair, 2015). Therefore, the next time you feel ill, you do not save any antibiotics. Then eventually remove all leftover medications after the recommended medication has been finished. It can be an excellent way to reduce medication resistance to antibiotics. If not done, it can continue and cannot be managed in the immediate vicinity.
Conclusion
The consequences could be catastrophic due to the failure to produce new antibiotics. Access to effective antibiotics has revolutionized public health and made countless advances in healthcare possible (Li, Plésiat, & Nikaido, 2015). The creation of developments in surgery and myeloablative cancer therapy and for both solid organ and hematopoietic stem cell transplantation is essential, for instance, in antibiotics. In patients with wounds and war attacks, as well as myocardial infarctions, strokes and other diseases that need extensive catheter therapy, hyper food supplementation and mechanical ventilation, successful antibiotics have also been necessary. Interestingly, the developments in medical treatments that have led to the development of large populations of ever-defeating hosts of modern, stronger pathogens owing to successful antibiotic therapy also lead to infections of more or less immune microbes.
Reference
Berendonk, T. U., Manaia, C. M., Merlin, C., Fatta-Kassinos, D., Cytryn, E., Walsh, F., … & Kreuzinger, N. (2015). Tackling antibiotic resistance: the environmental framework. Nature Reviews Microbiology, 13(5), 310-317.
Blair, J. M., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. (2015). Molecular mechanisms of antibiotic resistance. Nature reviews microbiology, 13(1), 42-51.
Chellat, M. F., Raguž, L., & Riedl, R. (2016). Targeting antibiotic resistance. Angewandte Chemie International Edition, 55(23), 6600-6626.
Demirjian, A., Sanchez, G. V., Finkelstein, J. A., Ling, S. M., Srinivasan, A., Pollack, L. A., … & Iskander, J. K. (2015). CDC grand rounds: getting smart about antibiotics. MMWR. Morbidity and mortality weekly report, 64(32), 871.
Frieri, M., Kumar, K., & Boutin, A. (2017). Antibiotic resistance. Journal of infection and public health, 10(4), 369-378.
https://www.cdc.gov/
Li, X. Z., Plésiat, P., & Nikaido, H. (2015). The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clinical microbiology reviews, 28(2), 337-418.
Munita, J. M., & Arias, C. A. (2016). Mechanisms of antibiotic resistance. Virulence mechanisms of bacterial pathogens, 481-511.
Thung, I., Aramin, H., Vavinskaya, V., Gupta, S., Park, J. Y., Crowe, S. E., & Valasek, M. A. (2016). The global emergence of Helicobacter pylori antibiotic resistance. Alimentary pharmacology & therapeutics, 43(4), 514-533.
Ventola, C. L. (2015). The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and therapeutics, 40(4), 277.
World Health Organization. (2015). Antibiotic resistance: Multi-country public awareness survey.